Many of the 75 million Americans with essential hypertension also develop diabetes and other complications in addition to their high blood pressure, and researchers have discovered a common molecular mechanism in a strain of rat that explains why such metabolic disorders arise together in mammals.
The bioengineering researchers at UC San Diego’s Read the rest of this entry »

For the first time, researchers from the University of Pittsburgh School of Medicine have identified genetic components of dendritic cells that are key to asthma and allergy-related immune response malfunction. Targeting these elements could result in more effective drugs to treat allergic disorders and asthma, according Read the rest of this entry »

Wholesnax has recalled some batches of its chocolate coated brazils, peanuts, raisins, peanuts and raisins and mixed nuts and raisins because they contain soya lecithin which is declared as lecithin in the ingredients list. The products, therefore, are unsuitable for people with a soya allergy. The Agency has issued an Allergy Alert.
Anyone with a soya allergy is advised not to eat these products. Read the rest of this entry »

Pharmacopeia (Nasdaq:
PCOP), an innovator in the discovery and development of novel small
molecule therapeutics, announced that PS433540, its first-in-class
Dual Acting Receptor Antagonist (DARA), showed statistically significant
blood pressure reductions in a Phase 2a study in patients with mild to
moderate hypertension. PS433540 is being developed Read the rest of this entry »

ISTA
Pharmaceuticals, Inc. (Nasdaq: ISTA), announced positive results from
the preliminary analysis of its second and final Bepreve(TM) (bepotastine
ophthalmic solution) Phase III clinical study. The U.S. multi-center
conjunctival allergen challenge (CAC) study evaluated the onset and
duration of effect of two Bepreve concentrations in 130 patients with a
history of ocular allergies. Both concentrations demonstrated highly
statistically significant Read the rest of this entry »